Assessment of Coronary Risk Based on Cumulative Exposure to Lipids in Systemic Lupus Erythematosus

REFERENCES

1. 1.↵
   1. Nikpour M,
   2. Urowitz MB,
   3. Gladman DD

   . Epidemiology of atherosclerosis in systemic lupus erythematosus. Current Rheum Rep 2009;11:248–54.

   OpenUrlCrossRef
2. 2.↵
   Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002;106:3143–421.

   OpenUrlFREE Full Text
3. 3.↵
   1. Grundy SM,
   2. Cleeman JI,
   3. Merz CN,
   4. Brewer HB Jr.,
   5. Clark LT,
   6. Hunninghake DB,
   7. et al.

   Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 2004;110:227–39.

   OpenUrlAbstract/FREE Full Text
4. 4.↵
   1. Nikpour M,
   2. Gladman DD,
   3. Ibanez D,
   4. Harvey PJ,
   5. Urowitz MB

   . Variability over time and correlates of cholesterol and blood pressure in systemic lupus erythematosus: a longitudinal cohort study. Arthritis Res Ther 2010;12:R125.

   OpenUrlCrossRefPubMed
5. 5.↵
   1. Nikpour M,
   2. Urowitz MB,
   3. Ibanez D,
   4. Harvey PJ,
   5. Gladman DD

   . Importance of cumulative exposure to elevated cholesterol and blood pressure in development of atherosclerotic coronary artery disease in systemic lupus erythematosus: a prospective proof-of-concept cohort study. Arthritis Res Ther 2011;13:R156.

   OpenUrlCrossRefPubMed
6. 6.↵
   1. Friedewald WT,
   2. Levy RI,
   3. Fredrickson DS

   . Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499–502.

   OpenUrlAbstract/FREE Full Text
7. 7.↵
   1. Svenungsson E,
   2. Gunnarsson I,
   3. Fei GZ,
   4. Lundberg IE,
   5. Klareskog L,
   6. Frostegard J

   . Elevated triglycerides and low levels of high-density lipoprotein as markers of disease activity in association with up-regulation of the tumor necrosis factor alpha/tumor necrosis factor receptor system in systemic lupus erythematosus. Arthritis Rheum 2003;48:2533–40.

   OpenUrlCrossRefPubMed
8. 8.↵
   1. Petri M,
   2. Lakatta C,
   3. Magder L,
   4. Goldman D

   . Effect of prednisone and hydroxychloroquine on coronary artery disease risk factors in systemic lupus erythematosus: a longitudinal data analysis. Am J Med 1994;96:254–9.

   OpenUrlCrossRefPubMed
9. 9.↵
   1. Ibanez D,
   2. Gladman DD,
   3. Urowitz MB

   . Adjusted mean Systemic Lupus Erythematosus Disease Activity Index-2K is a predictor of outcome in SLE. J Rheumatol 2005;32:824–7.

   OpenUrlAbstract/FREE Full Text
10. 10.↵
    1. Svenungsson E,
    2. Jensen-Urstad K,
    3. Heimburger M,
    4. Silveira A,
    5. Hamsten A,
    6. de Faire U,
    7. et al.

    Risk factors for cardiovascular disease in systemic lupus erythematosus. Circulation 2001;104:1887–93.

    OpenUrlAbstract/FREE Full Text
11. 11.↵
    1. Borba EF,
    2. Bonfa E

    . Dyslipoproteinemias in systemic lupus erythematosus: influence of disease, activity, and anticardiolipin antibodies. Lupus 1997;6:533–9.

    OpenUrlAbstract/FREE Full Text
12. 12.↵
    1. de Carvalho JF,
    2. Borba EF,
    3. Viana VS,
    4. Bueno C,
    5. Leon EP,
    6. Bonfa E

    . Anti-lipoprotein lipase antibodies: a new player in the complex atherosclerotic process in systemic lupus erythematosus? Arthritis Rheum 2004;50:3610–5.

    OpenUrlCrossRefPubMed
13. 13.↵
    1. Avins AL,
    2. Neuhaus JM

    . Do triglycerides provide meaningful information about heart disease risk? Arch Intern Med 2000;160:1937–44.

    OpenUrlCrossRefPubMed
14. 14.↵
    1. Castelli WP

    . Cardiovascular disease and multifactorial risk: challenge of the 1980s. Am Heart J 1983;106:1191–200.

    OpenUrlCrossRefPubMed
15. 15.↵
    1. Gordon T,
    2. Castelli WP,
    3. Hjortland MC,
    4. Kannel WB,
    5. Dawber TR

    . High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am J Med 1977;62:707–14.

    OpenUrlCrossRefPubMed
16. 16.↵
    1. Romm PA,
    2. Green CE,
    3. Reagan K,
    4. Rackley CE

    . Relation of serum lipoprotein cholesterol levels to presence and severity of angiographic coronary artery disease. Am J Cardiol 1991;67:479–83.

    OpenUrlCrossRefPubMed
17. 17.↵
    1. Ansell BJ,
    2. Fonarow GC,
    3. Fogelman AM

    . The paradox of dysfunctional high-density lipoprotein. Curr Opin Lipidol 2007;18:427–34.

    OpenUrlCrossRefPubMed
18. 18.↵
    1. McMahon M,
    2. Grossman J,
    3. FitzGerald J,
    4. Dahlin-Lee E,
    5. Wallace DJ,
    6. Thong BY,
    7. et al.

    Proinflammatory high-density lipoprotein as a biomarker for atherosclerosis in patients with systemic lupus erythematosus and rheumatoid arthritis. Arthritis Rheum 2006;54:2541–9.

    OpenUrlCrossRefPubMed
19. 19.↵
    1. McMahon M,
    2. Grossman J,
    3. Skaggs B,
    4. Fitzgerald J,
    5. Sahakian L,
    6. Ragavendra N,
    7. et al.

    Dysfunctional proinflammatory high-density lipoproteins confer increased risk of atherosclerosis in women with systemic lupus erythematosus. Arthritis Rheum 2009;60:2428–37.

    OpenUrlCrossRefPubMed
20. 20.↵
    1. Petri MA,
    2. Kiani AN,
    3. Post W,
    4. Christopher-Stine L,
    5. Magder LS

    . Lupus Atherosclerosis Prevention Study (LAPS). Ann Rheum Dis 2011;70:760–5.

    OpenUrlAbstract/FREE Full Text
21. 21.↵
    1. Plazak W,
    2. Gryga K,
    3. Dziedzic H,
    4. Tomkiewicz-Pajak L,
    5. Konieczynska M,
    6. Podolec P,
    7. et al.

    Influence of atorvastatin on coronary calcifications and myocardial perfusion defects in systemic lupus erythematosus patients: a prospective, randomized, double-masked, placebo-controlled study. Arthritis Res Ther 2011;13:R117.

    OpenUrlCrossRefPubMed
22. 22.↵
    1. Fodor JG,
    2. Frohlich JJ,
    3. Genest JJ Jr.,
    4. McPherson PR

    . Recommendations for the management and treatment of dyslipidemia. Report of the Working Group on Hypercholesterolemia and Other Dyslipidemias. CMAJ 2000;162:1441–7.

    OpenUrlFREE Full Text